Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TELSTAR-2: Anti-seizure Treatment for ESE in Comatose Cardiac Arrest Patients
NCT06549426Recruiting
- Sponsor
- University of Twente
- Start
- Apr 2025
- Primary completion
- Dec 2029
- Countries
- 2
01
Overview
Randomised, open-label trial in Electrographic Status Epilepticus (NCSE) (2 arms), sponsored by University of Twente. Primary endpoint: Extended Glasgow Outcome Scale at 6 months. Started Apr 2025; status: recruiting.
02
Conditions
Electrographic Status Epilepticus (NCSE)
Beyond the preview
Go deeper on NCT06549426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06549426.